Wardray Premise has been appointed as the UK and Ireland Distributor for the TOF Watch. The TOF Watch series offers an accurate and reliable method of objective acceleromyographic (AMG) monitoring of neuromuscular blockade that overcomes the limitations of subjective monitoring.
Patients monitored with a TOF Watch experienced a significantly lower incidence of residual blockade train of four (TOF) <0.9 when compared with patients monitored subjectively by clinical exam alone or with a peripheral nerve simulator lacking an objective display. This equates to 30% for those monitored subjectively, to 4.5% with the TOF Watch.
Recovery to a TOF<0.9 has been associated with a wide range of side effects. The TOF Watch helps to ensure patients are recovered to a TOF>0.9 before extubation. In addition to being able to be used in various clinical settings, the TOF Watch can be used at various anatomical sites, depending on the needs of surgery. The most common site for TOF measurement is the abductor pollcis (thumb). Alternative sites for measurement are the orbicularis oculi or the corrugator supercilli, above the eye, and the flexor hallucis brevis muscle, at the toe.
The TOF Watch series consists of 3 models: TOF Watch, TOF Watch S and TOF Watch SX. All three models accurately measure the depth of Neuromuscular blockade to help assess:
• Onset time of neuromuscular blocking agents (NMBA’s).
• The need for administration of maintenance doses of NMBA’s.
• When to administer a reversal agent.
• When to safely extubate a patient.
